| Jeffrey Jay Jordan, MD | |
|
900 Hammond St # A, Bangor, ME 04401-4378 | |
| (207) 947-6743 | |
| (207) 945-4397 |
| Full Name | Jeffrey Jay Jordan |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 30 Years |
| Location | 900 Hammond St # A, Bangor, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861480246 | NPI | - | NPPES |
| 258930099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 014810 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Maine Eye Associates Pa | 8820031610 | 3 |
News Archive
Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.
New research conducted by Harvard scientists is laying out a roadmap to one of the holy grails of modern medicine - a cure for cancer.
Using cats as an animal model to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, researchers have determined the virus has a narrow transmission bottleneck.
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
› Verified 7 days ago
| Entity Name | Eastern Maine Eye Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679563076 PECOS PAC ID: 8820031610 Enrollment ID: O20050602000747 |
News Archive
Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.
New research conducted by Harvard scientists is laying out a roadmap to one of the holy grails of modern medicine - a cure for cancer.
Using cats as an animal model to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, researchers have determined the virus has a narrow transmission bottleneck.
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
› Verified 7 days ago
| Entity Name | Bangor Eye Surgery, Pa |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1215309653 PECOS PAC ID: 7416241013 Enrollment ID: O20160804000972 |
News Archive
Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.
New research conducted by Harvard scientists is laying out a roadmap to one of the holy grails of modern medicine - a cure for cancer.
Using cats as an animal model to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, researchers have determined the virus has a narrow transmission bottleneck.
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Jay Jordan, MD 900 Hammond St # A, Bangor, ME 04401-4378 Ph: (207) 947-6743 | Jeffrey Jay Jordan, MD 900 Hammond St # A, Bangor, ME 04401-4378 Ph: (207) 947-6743 |
News Archive
Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel.
New research conducted by Harvard scientists is laying out a roadmap to one of the holy grails of modern medicine - a cure for cancer.
Using cats as an animal model to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, researchers have determined the virus has a narrow transmission bottleneck.
Despite the promising findings of the PROTECT Pilot study, the larger PROTECT trial found no difference with rolofylline versus placebo with respect of the primary and main secondary end-points of the study. Although more rolofylline patients than placebo patients experienced moderate or marked dyspnea improvement at 24 and 48 hours from randomization, this was counterbalanced by a lack of effect on persistent renal impairment. Lastly, the risk of important neurological events was increased in patients on rolofylline.
The Biofactory, a biomedical incubator based in Singapore, has launched a new genetic test at MEDICA 2012, the world's largest medical trade fair. Called FastFraX, this genetic test is able to effectively screen for Fragile X Syndrome (FXS), a genetic condition that is the most common form of inherited intellectual disability.
› Verified 7 days ago
Dr. Deborah S Hoffert, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 700 Mount Hope Ave Ste 470, Evergreen Woods, Bangor, ME 04401 Phone: 207-945-4474 Fax: 207-941-5913 | |
Theodore Curtis, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 885 Union St, Suite 120/130, Bangor, ME 04401 Phone: 207-973-8876 Fax: 207-973-6058 | |
Dr. Robert J Takach, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 12 Stillwater Ave, Bangor, ME 04401 Phone: 207-945-4474 | |
Paul Rush Moulton, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 5 Grove St, Bangor, ME 04401 Phone: 207-945-3619 | |
Garth Allen Wilbanks, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Hammond St # A, Bangor, ME 04401 Phone: 207-947-6743 Fax: 207-945-4397 | |
Cynthia Amanda Self, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 900 Hammond St # A, Bangor, ME 04401 Phone: 207-947-6743 Fax: 207-945-4397 | |
Anthony S Ekong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 336 Mount Hope Ave Ste 1, Bangor, ME 04401 Phone: 207-573-1509 Fax: 207-573-1750 |